AETHLON MEDICAL INC (AEMD): Nasdaq/NYSE listing notice — Aethlon Medical gets 180-day Nasdaq extension through June 23, 2025 for bid price rule

AETHLON MEDICAL INC

Received 180-day extension from Nasdaq until June 23, 2025 to regain $1.00 minimum bid price compliance.
Stock must close at $1.00+ for at least 10 consecutive trading days to regain compliance; non-compliant since June 2024.
Failure to regain compliance by June 23, 2025 may lead to delisting; Company could appeal to hearings panel.
Company intends to monitor bid price and consider available options; no assurance of regaining compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

AETHLON MEDICAL INC received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

January 7, 2025, the Company received a letter from Nasdaq (the “Extension Notice”) advising that the Company has been granted a 180-day extension, or until June 23, 2025, to regain compliance with the Minimum Bid Price

View on SEC.gov

94 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

AETHLON MEDICAL INC filing history →

Source: SEC EDGAR

accession 0001683168-25-000150

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.